Home Immunocore completes $320 million (A 205 million) private financing round
 

Keywords :   


Immunocore completes $320 million (A 205 million) private financing round

2015-07-16 15:48:23| Biotech - Topix.net

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor based biological drugs to treat cancer, viral infections and autoimmune disease, today announced the completion of a US $320 million private financing round. The oversubscribed round includes new investors, Woodford Investment Management, Malin Corporation plc, Eli Lilly and Company and RTW Investments, as well as a number of new and existing investors in Immunocore.

Tags: private million round financing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
12.11
12.11Helinoxsunsetchair
12.11898 EX SR PSA10 87
12.11 UMIZARU EVOLUTION DVD5
12.11King&Prince Re:ERA
12.11
12.11in
12.11
More »